Related Experiment Video

Updated: Jul 25, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

Hyperhomocyst(e)inemia

Key1

  • 1University of Minnesota Medical School and Minnesota Vascular Diseases Center, Box 480 Mayo, Harvard St. at East River Road, Minneapolis, MN 55455, USA.

Current Treatment Options in Cardiovascular Medicine
|November 30, 2000
PubMed

Insights

High homocysteine levels (hyperhomocysteinemia) may increase cardiovascular risk. While low vitamin intake is a common cause, further research is needed to confirm if vitamin supplementation effectively prevents atherosclerotic disease.

Area of Science:

  • Cardiovascular Science
  • Nutritional Science
  • Epidemiology

Background:

  • Hyperhomocysteinemia is increasingly recognized as a risk factor for atherosclerotic disease across arterial circulations.
  • It is also associated with an increased risk of venous thromboembolism.
  • Low dietary intake of vitamin B6 and folic acid is the primary cause of elevated homocysteine levels.

Purpose of the Study:

  • To investigate whether hyperhomocysteinemia itself or other effects of vitamin deficiency contribute to cardiovascular risk.
  • To determine the efficacy of vitamin supplementation in preventing atherosclerotic disease through prospective randomized studies.

Main Methods:

  • Prospective epidemiologic studies are underway to address the relationship between homocysteine and cardiovascular risk.
  • The need for prospective randomized trials to evaluate vitamin supplementation for primary and secondary prevention of atherosclerotic disease is highlighted.

Main Results:

  • The precise role of hyperhomocysteinemia versus vitamin deficiency in cardiovascular risk remains an unresolved question.
  • Evidence from ongoing studies is crucial for clarifying the causative factors.

Conclusions:

  • Lifestyle modifications and vitamin supplementation to lower homocysteine are recommended as safe interventions.
  • Definitive evidence is required before advocating treatments with higher potential toxicity for hyperhomocysteinemia.
  • Further research, particularly randomized controlled trials, is essential to establish clinical benefits.

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Isolation of Primary Mouse Retinal Pigmented Epithelium Cells06:21

Isolation of Primary Mouse Retinal Pigmented Epithelium Cells

Published on: November 4, 2022

Related Concept Videos

Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...